Nanjing Discovery pharma is a one-stop innovative product and service provider in the field of pharmaceutical R&D and manufacturing in China. The company is committed to helping partners enhance the efficiency of new drug discovery and development through chemical technology innovation in R&D and production processes, accelerating the market launch of projects. Since its inception, Discovery pharma Pharmaceutical has collaborated with hundreds of small and medium-sized biopharmaceutical technology companies nationwide. Through years of dedicated research and leveraging its outstanding capabilities in the design, synthesis, and supply of drug molecular building blocks, Discovery pharma Pharmaceutical has established a diverse and structurally novel library of drug molecular building blocks for domestic pharmaceutical R&D enterprises. This library enables drug discovery companies to rapidly access a large number of candidate compounds for screening and evaluation during the drug discovery phase, efficiently completing the design-synthesis-testing cycle while significantly reducing the time and economic costs of drug development. While continuously expanding its range of laboratory-scale molecular building blocks, Discovery pharma Pharmaceutical has strengthened its process R&D and production capabilities for drug molecular building blocks, achieving large-scale production and supply of thousands of products. Leveraging its molecular building block resources, Discovery pharma has developed a fragment-based molecular library and multiple drug discovery technologies. Using these as platforms, it has established a collaborative model based on "shared risks and benefits."